The Three Pillars
1
Pillar One
Fuel
The failing heart preferentially oxidises ketones and fatty acids over glucose. As cardiac glucose metabolism becomes impaired, the heart upregulates fat and ketone utilisation. Feed that pathway directly. CoQ10, dietary fat, ketone availability, omega 3. The Trace ketones already showing in strips confirm the pathway is active. The goal is to make it run stronger.
2
Pillar Two
Dilate
The cardiac workload is determined by the resistance the heart pumps against. Lower the resistance, lower the work. Candesartan and doxazosin are already doing this pharmacologically. Nitric oxide does it naturally — nasal humming, dietary nitrates, nasal breathing. Stack natural NO production on top of pharmaceutical vasodilation for additive effect. Measurable on the nitrite pad.
3
Pillar Three
Reduce Load
Heart failure is an inflammatory condition. Systemic inflammation drives cardiac fibrosis, reduces contractility, and accelerates deterioration. Reduce the inflammatory load — omega 3, magnesium, D3/K2, movement — and the heart has more capacity to repair. hsCRP is the monitoring marker. Strips monitor fluid balance and renal function under this medication load.
Daily Protocol — Pillar 1 · Fuel
CoQ10 — 200mg Ubiquinol Form
Daily · Morning
The heart has the highest CoQ10 concentration of any organ. Heart failure depletes it — studies show 25-40% reduction in cardiac CoQ10 in heart failure patients. Supplementing directly fuels the electron transport chain in cardiac mitochondria. Ubiquinol form (reduced) has superior bioavailability over ubiquinone, especially at 74. 200mg is the therapeutic dose for heart failure specifically. Q-SYMBIO trial showed significant reduction in cardiac events.
Strip marker: Ketones. Rising or sustained Trace-Small = fat oxidation running. If ketones fall to consistently Neg = metabolic flexibility reducing.
Omega 3 — 3g EPA/DHA Daily
Daily · With Food
EPA and DHA reduce cardiac inflammation, lower triglycerides, reduce arrhythmia risk, and improve cardiac membrane fluidity. REDUCE-IT trial showed 25% reduction in cardiovascular events with high-dose omega 3 in high-risk patients. Her atorvastatin is already working on LDL — omega 3 addresses the triglyceride and inflammation component atorvastatin doesn't touch. Use a high-quality triglyceride form (not ethyl ester). Bare Biology or Nordic Naturals.
Strip marker: No direct pad. Blood marker: hsCRP reduction over 8-12 weeks confirms anti-inflammatory effect.
Magnesium Glycinate — 300mg
Daily · Evening
Magnesium is essential for cardiac rhythm, blood pressure regulation, and muscle contractility. Heart failure and diuretics (spironolactone) both deplete magnesium chronically. Low magnesium increases arrhythmia risk and reduces cardiac contractility. Glycinate form is well absorbed and gentle on the gut. Evening dosing supports sleep quality and overnight cardiac repair. Caution: candesartan can raise potassium — check with GP if adding high-dose magnesium alongside potassium-affecting medications.
Strip marker: Indirect. SG stability indicates electrolyte balance is being maintained.
D3 4000IU + K2 200mcg
Daily · Morning
Vitamin D deficiency is almost universal in heart failure and independently predicts cardiac outcomes. D3 supports cardiac muscle function, immune regulation, and blood pressure. K2 (MK-7 form) directs calcium away from arterial walls and into bone — critical given she's 74 and on medications that affect calcium metabolism. D3 and K2 must be taken together. At 74 with heart failure, 4000IU D3 is appropriate — get a blood 25-OH Vitamin D test if possible to confirm before starting high dose.
Strip marker: Indirect. No direct pad. Supports ACR stability through renal protective mechanisms.
Daily Protocol — Pillar 2 · Dilate
Nasal Humming Protocol — 10 Minutes
Daily · Morning
Nasal humming produces a 15-fold increase in nasal NO production through oscillating airflow across the sinus mucosa. NO is a potent vasodilator — it relaxes vascular smooth muscle, reduces peripheral resistance, and directly reduces the pressure the heart pumps against. This stacks on top of candesartan and doxazosin which are doing the same thing pharmacologically. Gentle seated humming, low comfortable frequency, exhale through nose. 10 minutes daily. No exertion required. Safe regardless of cardiac status.
Strip marker: Nasal strip nitrite. Post-humming nasal strip should read positive — confirms NO pathway is active and measurable.
Dietary Nitrates — Green Vegetables
Daily · With Meals
Dietary nitrates from leafy greens (beetroot, spinach, rocket, lettuce) are converted to nitrite by oral bacteria, then to NO in the stomach and vasculature. This is the oral bacterial NO pathway confirmed in the family dataset. Beetroot juice (shot form) provides the highest nitrate density — 1 small shot 2 hours before the humming protocol produces maximum stacking effect. No mouthwash before or after — it kills the oral bacteria doing the conversion.
Strip marker: Oral nitrite strip. Positive = oral bacterial pathway active. No toothbrushing 30min before strip.
Nasal Breathing Priority
Daily · All Activity
Nasal breathing during all waking activity — walking, sitting, light exercise — continuously produces NO from sinus epithelium. Mouth breathing bypasses the entire NO production system. At rest this is achievable with attention. The cumulative effect of sustained nasal breathing throughout the day is significant NO elevation that supports ongoing vasodilation. Mouth taping at night (low-allergen surgical tape across lips) trains nasal breathing during sleep — noticeable improvement in sleep quality within one week for most people.
Strip marker: Resting nasal strip. Increasing positivity over weeks = sinus NO pathway strengthening.
Daily Protocol — Pillar 3 · Reduce Load
Movement — 20-30 Minutes Walking Daily
Daily
She's already active — this isn't about adding exercise, it's about structuring the movement she already does. Daily walking at comfortable pace maintains peripheral vascular tone, reduces systemic inflammation, supports lymphatic drainage, and keeps skeletal muscle efficient — which directly reduces the cardiac workload by improving oxygen extraction at the muscle level. The heart doesn't have to pump as hard to deliver the same oxygen. Nasal breathing during walking stacks NO production on top of the movement benefit.
Strip marker: SG 1.005-1.010 post-walk confirms good hydration management around activity.
hsCRP Baseline — Finger Prick Blood Test
This Week
High-sensitivity CRP is the single most important monitoring marker for this protocol. Heart failure is driven by systemic inflammation and hsCRP is the best accessible measure of it. Medichecks postal finger prick test, approximately £20, results online within 48hrs. This establishes the baseline that everything else is measured against. Retest at 8 weeks and 16 weeks. If hsCRP is falling, the protocol is working. If not, something needs adjusting. Without this number the anti-inflammatory intervention is unmonitored.
Target: Below 1.0 mg/L optimal. 1.0-3.0 moderate risk. Above 3.0 high inflammation — escalate protocol.
Sleep — 7-8 Hours, Nasal Breathing
Daily
Cardiac repair happens during sleep. Growth hormone release, tissue regeneration, and inflammatory clearance all peak during deep sleep. Heart failure patients have elevated sympathetic tone that disrupts sleep — the magnesium glycinate in the evening protocol directly supports this. Nasal breathing during sleep also means continuous low-level NO production throughout the night, sustained vasodilation, and reduced cardiac workload during the repair window.
Strip marker: AM first void SG. Consistent 1.005-1.010 on waking = good overnight fluid balance.
Strip Interpretation Map — Her Medication Profile
Glucose
Ignore
Dapagliflozin (SGLT2 inhibitor) — always positive by design. This is the mechanism of the drug. Completely uninformative. Never use this pad for her.
Ketones
Valid
Most important metabolic marker for her. Trace = fat oxidation running, cardiac fuel pathway active. Rising toward Small = improving fat metabolism. Neg = metabolic flexibility reducing — flag this.
Nitrite
Valid
Key protocol marker. Post-humming nasal strip positive = NO pathway active. Oral strip positive = dietary nitrate conversion working. This is the measurable output of Pillar 2.
Blood
Valid · Priority
Most clinically important pad for her. Any blood positive = GP same week. At 74 with heart failure, blood in urine warrants prompt investigation. Aspirin may cause very occasional trace — context matters.
Leukocytes
Caution
Spironolactone metabolites can cause false positive. If positive, retest 24hrs later. If still positive = treat as genuine UTI — GP same day. UTI at 74 with heart failure can deteriorate rapidly.
Protein
May be masked
Candesartan (ARB) reduces proteinuria — a negative read doesn't guarantee clean kidneys. Monthly ACR test is more reliable than protein pad for her. Trace protein = note and monitor. Positive = GP.
SG
Adjusted Range
Spironolactone diuretic effect means her normal SG is 1.003-1.010. This is not under-hydration for her. SG above 1.020 = dehydration risk — important with cardiac medication. Drink water.
pH
Valid
Her baseline is 6.5 — confirmed across all reads. This is her personal age-related baseline. Significant shift alkaline (above 7.5) = possible UTI. Significant acid (below 5.5) = flag.
ACR
Monthly · Unreliable Daily
Glucosuria from dapagliflozin interferes with creatinine measurement affecting ACR ratio. Monthly ACR tests should be done with this caveat noted. Track trend over months not individual readings.
Monitoring Targets — What Success Looks Like
↓
hsCRP
Target below 1.0 mg/L. Starting point unknown. Retest every 8 weeks. Falling = protocol working.
+
Nasal Nitrite
Post-humming strip positive. Consistently positive = NO pathway active and sustained.
Trace
Ketones
Sustained Trace or rising to Small = cardiac fat fuel pathway running. Never Neg.
Neg
Blood + Leukocytes
Consistent negative on both = kidneys and urinary tract clean under medication load.
Milestone Timeline
Week 1
Start CoQ10, omega 3, magnesium glycinate, D3/K2. Begin nasal humming protocol 10 minutes daily. Order hsCRP finger prick test. Establish daily AM strip protocol. First nasal strip post-humming — confirm NO pathway positive.
Strip: AM urine + post-humming nasal
Week 2
hsCRP baseline result in. Log as Week 0 reference. Add beetroot shot protocol 2hrs before morning humming. Check supplement tolerability — any GI issues, adjust. Note any change in energy or pain levels subjectively.
Blood: hsCRP baseline
Week 4
First month checkpoint. Are ketones consistent Trace on morning strips? Is nasal humming producing nitrite positive reliably? Any subjective change in energy, breathlessness, pain? Thoracic MRI results should be in — add movement protocol based on findings.
Review: strips + subjective markers
Week 8
Second hsCRP test. Compare to Week 2 baseline. If falling: protocol is working, continue and escalate. If static: review diet, increase omega 3 dose, add turmeric/curcumin. If rising: GP review — something else may be driving inflammation.
Blood: hsCRP comparison
Month 3
Full review. hsCRP trend established. Strip baseline consolidated. Share data with cardiologist — ketone trend, nitrite activity, strip stability. This is the first evidence-based conversation about medication review. The data makes the case, not the subjective report.
GP/Cardio: data-led medication review
Month 6
If hsCRP has fallen significantly, cardiac workload markers are stable, and energy/exercise tolerance has improved — formal request for echocardiogram to compare to baseline. Ejection fraction improvement is possible with sustained protocol adherence over 6 months.
Target: Echo comparison to baseline
Full Medication Reference
Dapagliflozin 10mg · Daily
SGLT2 inhibitor. Blocks kidney glucose reabsorption — excretes glucose in urine. Heart failure + possible T2DM. Also reduces cardiac inflammation and fibrosis directly.
Glucose pad: ALWAYS positive — ignore completely. ACR: unreliable. Protein: may be elevated from glucosuria interference.
Candesartan 32mg · Daily
ARB — angiotensin receptor blocker. Vasodilation, reduces cardiac workload, kidney protection. High dose = significant BP reduction.
Protein pad: may mask early protein leak. ACR: ARB reduces proteinuria — negative not guaranteed to be truly clean.
Spironolactone 25mg · Daily
Aldosterone antagonist / K-sparing diuretic. Reduces fluid retention, protects kidneys in heart failure, reduces cardiac fibrosis.
SG: expect 1.003-1.010 — this is normal for her. Leukocytes: metabolites may cause false positive. Nitrite: minor interference possible.
Doxazosin 4mg · Twice Daily
Alpha-1 blocker. Vasodilation, blood pressure reduction. Twice daily = sustained effect. Works synergistically with candesartan.
Minimal direct strip interference. SG may run slightly low.
Atorvastatin 80mg · Night
High-intensity statin. LDL reduction, plaque stabilisation, anti-inflammatory. 80mg = maximum standard dose.
Urobilinogen: statin liver effect may alter slightly. Protein: very rare at this dose.
Aspirin 75mg · Daily
Antiplatelet. Prevents clot formation. Standard cardiac prevention.
Blood pad: may cause occasional trace — context matters. Low dose, minimal effect.
Atenolol · (confirm if still active)
Beta-1 blocker. Slows heart rate, reduces cardiac workload. Not on current 23/03/2026 prescription — confirm with GP if still prescribed.
Glucose: reported to elevate glucose oxidase readings.
Lactulose · Habitual
Osmotic laxative. Habitual use — dose unknown. Consider switching to macrogol (Movicol) which is not systemically absorbed and does not interfere with strips.
Glucose pad: cross-reacts with glucose oxidase. Note: dapagliflozin already makes glucose pad uninformative — lactulose is now a secondary irrelevant confound.
Co-Codamol · Recent
Paracetamol + codeine. Pain relief for thoracic pain. Recent addition.
Minimal direct strip interference.
The Philosophy — Why This Works
The medications are managing the condition. The protocol is treating the cause.
Heart failure is not a static endpoint — it is a dynamic state driven by inflammation, fuel deficit, and vascular resistance. Address all three simultaneously with measurable interventions and the trajectory changes. The cardiologists will see it in the data before they can explain it by their standard model.
The strips are the daily feedback loop. The hsCRP is the monthly report card. The echo in six months is the outcome measure. Everything is observable. Nothing is guessed.
The goal is not to replace the medications — it is to make them less necessary over time by removing the conditions that make them necessary in the first place.
Heart failure is not a static endpoint — it is a dynamic state driven by inflammation, fuel deficit, and vascular resistance. Address all three simultaneously with measurable interventions and the trajectory changes. The cardiologists will see it in the data before they can explain it by their standard model.
The strips are the daily feedback loop. The hsCRP is the monthly report card. The echo in six months is the outcome measure. Everything is observable. Nothing is guessed.
The goal is not to replace the medications — it is to make them less necessary over time by removing the conditions that make them necessary in the first place.